Author(s): Nico Gagelmann, Diderik-Jan Eikema, Linda Koster, et al. Abstract: S129 Session topic: 16. Myeloproliferative neoplasms – Clinical Background A recent model using clinical-molecular features of patients with secondary myelofibrosis (sMF) was developed by MYSEC (MYelofibrosis SECondary to PV and ET project) showing better prediction of outcome compared with the International Prognostic...
Pro zobrazení tohoto obsahu je třeba být přihlášen.